Three Cases of Zolpidem Dependence Treated with Fluoxetine: The Serotonin Hypothesis
- 1 January 2003
- journal article
- case report
- Published by Taylor & Francis in The World Journal of Biological Psychiatry
- Vol. 4 (2), 93-96
- https://doi.org/10.3109/15622970309167957
Abstract
Zolpidem is an imidazopyridine hypnotic that is believed to act selectively at alpha(1) subunit-containing gamma-aminobutyric acid type A (GABA(A)) receptors and thus to have minimal abuse and dependence potential. We present three cases of zolpidem abuse and dependence in which the drug was used not for sedation but for stimulation and anxiolysis. All of the patients were treated with fluoxetine (a selective serotonin reuptake inhibitor) and managed to discontinue the abuse and remain abstinent from the drug. The efficacy of this kind of medication on the abuse of a GABAergic agonist, in this case dependence on zolpidem, leads to a serotonergic and GABAergic system interaction hypothesis.Keywords
This publication has 10 references indexed in Scilit:
- Abuse, Dependence, and Epileptic Seizures after Zolpidem Withdrawal[colon] Review and Case ReportClinical Neuropharmacology, 2000
- ZolpidemDrugs, 2000
- Zolpidem Dependence and Prescription FraudThe American Journal on Addictions, 2000
- Role of serotonin in memory impairmentAnnals of Medicine, 2000
- Presynaptic serotonergic inhibition of GABAergic synaptic transmission in mechanically dissociated rat basolateral amygdala neuronsThe Journal of Physiology, 1999
- Role of GABAA Receptors in the Regulation of Sleep: Initial Sleep Responses to Peripherally Administered Modulators and AgonistsSleep, 1999
- GABAA-receptor Subtypes: Clinical Efficacy and Selectivity of Benzodiazepine Site LigandsAnnals of Medicine, 1997
- Addiction: brain mechanisms and their treatment implicationsThe Lancet, 1996
- Chronic Abuse of ZolpidemPublished by American Medical Association (AMA) ,1994
- ZolpidemDrugs, 1990